Dr. Majerus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110Phone+1 314-362-7216Fax+1 314-362-8813
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2000 - 2003
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2000
- Saint Louis University School of MedicineClass of 1998
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 1999 - 2025
Clinical Trials
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 637 citationsStructure of von Willebrand factor cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpuraXinglong Zheng, Dominic W. Chung, Thomas K. Takayama, Elaine M. Majerus, J. Evan Sadler
The Journal of Biological Chemistry. 2001-11-02 - 59 citationsADAMTS13 and TTPXinglong Zheng, Elaine M. Majerus, J. Evan Sadler
Current Opinion in Hematology. 2002-09-01 - 88 citationsCleavage of the ADAMTS13 propeptide is not required for protease activity.Elaine M. Majerus, Xinglong Zheng, Elodee A. Tuley, J. Evan Sadler
The Journal of Biological Chemistry. 2003-11-21
Press Mentions
- Dr. Philip Majerus, Among the First to Discern Aspirin’s Heart Benefits, Dies at 79June 14th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: